RNU6-1101P

Across TCGA pan-cancer cohorts, RNU6-1101P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-1101P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNU6-1101P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1101P expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

CHOL, COAD, and KICH are the cancer types where RNU6-1101P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	II,III,IV	0.089	0.712	.001	90	view →
COAD	OS	Tertile	All	0.139	0.802	<.001	90	view →
KICH	DFS	Tertile	All	0.079	0.891	<.001	84	view →
LIHC	OS	Tertile	II,III,IV	0.059	0.772	<.001	45	view →
KIRC	OS	Tertile	All	0.472	0.670	.002	30	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	18	view →
LGG	OS	Tertile	All	0.634	0.892	.005	18	view →
CESC	DFS	Tertile	II,III,IV	0.173	0.705	.028	18	view →
HNSC	OS	Tertile	II,III,IV	0.892	0.655	.024	15	view →
BLCA	OS	Tertile	III,IV	0.837	0.528	.031	9	view →
SARC	DFS	Tertile	All	0.130	0.632	.045	9	view →
PAAD	OS	Tertile	All	0.216	0.639	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-1101P–CHOL (OS)

Open the CHOL breakdown →